ESTA Stock Overview
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Establishment Labs Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.46 |
| 52 Week High | US$79.88 |
| 52 Week Low | US$16.96 |
| Beta | 1.04 |
| 1 Month Change | -30.73% |
| 3 Month Change | -57.43% |
| 1 Year Change | -63.86% |
| 3 Year Change | -20.46% |
| 5 Year Change | -1.65% |
| Change since IPO | -1.17% |
Recent News & Updates
Recent updates
Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Aug 10
Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Apr 17Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Dec 14Establishment Labs drops 18% after new short report from Hindenburg Research
Oct 19Establishment Labs: Flat Earnings, Return On Investment Keep Buyers At Bay
Sep 24Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Sep 04Establishment Labs started at buy at B Riley on breast implants
Aug 24Health Check: How Prudently Does Establishment Labs Holdings (NASDAQ:ESTA) Use Debt?
Feb 23Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Sep 25Is Establishment Labs Holdings (NASDAQ:ESTA) Weighed On By Its Debt Load?
Jun 09Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Feb 24Did Establishment Labs Holdings' (NASDAQ:ESTA) Share Price Deserve to Gain 92%?
Jan 20
Establishment Labs reports Q4, FY20 prelim revenue guidance
Jan 11What You Need To Know About Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Investor Composition
Dec 16Shareholder Returns
| ESTA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.6% | 1.2% | 0.6% |
| 1Y | -63.9% | 0.1% | 14.6% |
Return vs Industry: ESTA underperformed the US Medical Equipment industry which returned 0% over the past year.
Return vs Market: ESTA underperformed the US Market which returned 13.6% over the past year.
Price Volatility
| ESTA volatility | |
|---|---|
| ESTA Average Weekly Movement | 13.3% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ESTA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: ESTA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 958 | Juan Chacon Quiros | https://www.establishmentlabs.com |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Establishment Labs Holdings Inc. Fundamentals Summary
| ESTA fundamental statistics | |
|---|---|
| Market Cap | US$654.50m |
| Earnings (TTM) | -US$71.52m |
| Revenue (TTM) | US$177.40m |
3.6x
P/S Ratio-8.8x
P/E RatioIs ESTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESTA income statement (TTM) | |
|---|---|
| Revenue | US$177.40m |
| Cost of Revenue | US$62.85m |
| Gross Profit | US$114.56m |
| Other Expenses | US$186.08m |
| Earnings | -US$71.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.77 |
| Gross Margin | 64.57% |
| Net Profit Margin | -40.32% |
| Debt/Equity Ratio | 607.9% |
How did ESTA perform over the long term?
See historical performance and comparison